Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about psilocybin therapy Recent news which mentions psilocybin therapy Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment August 14, 2024 Tickers KAYS NEWS Tags KAYS Benzinga Psychedelics From Benzinga Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions March 25, 2024 Tickers NEWS NUMIF Tags Utah psychedelics bill Psychedelics Benzinga From Benzinga Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More March 04, 2024 Tickers ATAI CMND CMPS CYBN Tags PSIL ENVB CMND From Benzinga Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients February 14, 2024 Tickers NEWS Tags Benzinga Psychedelics News From Benzinga Canadian At-Home Microdose Psilocybin Clinical Trial Finalized, Here Are The Details March 31, 2023 Tags Psilocybin Microdosing News Benzinga From Benzinga Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment March 28, 2023 Tickers RVVTF Tags RVVTF Penny Stocks Psychedelics From Benzinga Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support February 15, 2023 Tickers TRUFF Tags Canadian Controlled Drugs And Substances Act Benzinga Psychedelics From Benzinga Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants February 01, 2023 Tags Benzinga Psychedelics Legal From Benzinga Virginia Psychedelics: Legalizing Medical Use Of Psilocybin Gets A Thumbs Down January 20, 2023 Tags virginia Markets psilocybin therapy From Benzinga 2023 Could Be Make Or Break For Psychedelics In Missouri, This GOP Lawmaker Is Pushing For Change January 09, 2023 Tags Markets Cannabis psilocybin therapy From Benzinga What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways January 03, 2023 Tickers ATAI AWKNF CMND CMPS Tags News ATAI SILO From Benzinga Oregon's Final Rules For Psilocybin Services Are Ready, Learn What To Expect December 28, 2022 Tags Markets Oregon Health Authority Market News From Benzinga First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval December 27, 2022 Tickers KONEF NMLSF Tags clinical trial Cannabis Market News From Benzinga Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries December 21, 2022 Tags Health Canada Special Access Program Psychedelic/Assisted Therapies Markets From Benzinga Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial December 12, 2022 Tags Diamond Therapeutics Inc/ News Benzinga From Benzinga Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far December 12, 2022 Tickers CMPS Tags News treatment/resistant depression Markets From Benzinga DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again October 27, 2022 Tickers CSA DEA Tags Psychedelics Benzinga Legal From Benzinga In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider October 07, 2022 Tags Markets Measure 109 Market News From Benzinga Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes September 30, 2022 Tags News Health Care Cannabis From Benzinga Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying September 22, 2022 Tickers CMPS Tags News cluster headaches Markets From Benzinga Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation September 19, 2022 Tags USDA Prof/ David Nutt Government From Benzinga Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction September 16, 2022 Tickers RVVTF Tags RVVTF Psychedelics Neurological Disorders From Benzinga Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close? September 14, 2022 Tickers MSSTF Tags major depressive disorder Global Clinical Trial Authorization From Benzinga Psychedelics Companies Are Teaming Up To Offer Access Veterans September 13, 2022 Tickers AWKNF RVLWF Tags News Jamaica Penny Stocks From Benzinga Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees September 06, 2022 Tickers ATAI Tags Benzinga Psychedelics Psychedelics Investing From Benzinga Study Finds Psilocybin Anti-Depression Effects Last At Least One Year March 04, 2022 Tags contributors Benzinga psychedelics From Benzinga The Case For Psilocybin Therapy And Depression January 30, 2022 Tags Markets Psilocybin Market News From Benzinga ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments January 27, 2022 Tickers ATAI Tags Markets Market News Cannabis From Benzinga Psilocybin Therapy Combined With SSRI Antidepressants Is Possible, COMPASS Study Confirms December 13, 2021 Tickers CMPS Tags Markets Cannabis psyhedelics From Benzinga Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways November 29, 2021 Tickers ATAI CMPS Tags Benzinga Government ATAI Life Sciences From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.